More evidence of the problems of using HbA1c for diagnosing diabetes? The known knowns, the known unknowns and the unknown unknowns

Journal of Internal Medicine

Volumn 276, Issue 2, 2014, Pages 171-173

  Church, D ^a   Simmons, D ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C;

DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE MARKER; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; VENOUS BLOOD;

DIABETES MELLITUS; ERYTHROCYTE INDICES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE;

EID: 84904293604     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12200     Document Type: Editorial

References (27)

1. WHO. Use of glycated haemoglobin (HbA1C) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. Jan 14, 2011. http://www.who.int/cardiovascular_diseases/report-hba1c_2011_edited.pdf (accessed Dec 7, 2013).
2. John WG on behalf of the UK Department of Health Advisory Committee on Diabetes. Expert Position Statement. Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organisation. Diabet Med 2012;29: 1350-7.
3. Engström G, Smith JG, Persson M, Nilsson PM, Melander O, Hedblad B. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med 2014. doi: 10.1111/joim.12188. [Epub ahead of print].
4. UK Prospective Diabetes Study. UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 1998; 352: 837-53.
5. Mooy JM, Gootenhuis PA, de Vries H et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298-305.
6. Selvin E, Crainiceanu C, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545-51.
7. Chan AY, Swaninathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989; 35: 315-7.
8. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation. 2006. http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf (accessed Jan 20, 2012).
9. Gambino R. Glucose: a simple molecule that is not simple to quantify. Clin Chem 2007; 53: 2040-1.
10. American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007; 50: 2042-3.
11. The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. ADA Workgroup report. Diabetes Care 2009; 32: 1327-34.
12. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care 2011; 34: 518-23.
13. Sabanayagam C, Liew G, Tai ES et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes. Diabetologia 2009; 52: 1279-89.
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
15. McCance DR, Hanson RL, Charles MA et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308: 1323-8.
16. Engelgau MM, Thompson TJ, Herman WH et al. Comparison of fasting and 2-hour glucose and HbAlc levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 1997; 20: 785-91.
17. Colagiuri S, Borch-Johnsen K. DETECT-2: early detection of type 2 diabetes and IGT. Diabetes Voice 2003; 48: 11-3.
18. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-34.
19. American Diabetes Association. Standards of Medical Care in Diabetes-2007. Diabetes Care 2007; 30: S4-41.
20. Okawa T, Tsunekawa S, Seino Y, Hamada Y, Oiso Y. Deceptive HbA1c in a patient with pure red cell aplasia. Lancet 2013; 382: 366.
21. Arnold JG, McGowan HJ. Delay in diagnosis of diabetes mellitus due to inaccurate use of hemoglobin A1C levels. J Am Board Fam Med 2007; 20: 93-6.
22. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E. R Dudczak R. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 1982; 59: 1348-50.
23. Church D, Halsall D, Simmons D. Diagnosing diabetes using HbA1c: Please think carefully. June 21, 2010. http://www.bmj.com/rapid-response/2011/11/02/diagnosing-diabetes-using-hba1c-please-think-carefully (accessed Jan 20, 2012).
24. Starkman HS, Wacks M, Soeldner JS, Kim A. Effect of acute blood loss on glycosylated hemoglobin determinations in normal subjects. Diabetes Care 1983; 6: 291-4.
25. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004; 112: 126-8.
26. HbA1c methods and hemoglobin variants (HbS, HbC, HbE and HbD traits) [online]. National Glyco Standardization Program. Available from http://www.ngsp.org/interf.asp. (accessed Jan 20, 2012).
27. Koga M, Morita S, Saito H, Mukai M, Kasayama S. Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med 2007; 24: 843-7.